Comparison of Rescue Analgesia Requirement in Patients Undergoing Laparoscopic Cholecystectomy After Transversus Abdominal Plane (tap) Block Vs Local Anesthetic Wound Infiltration At the End of Surgery
TAP
1 other identifier
interventional
74
1 country
1
Brief Summary
patients undergoing laparoscopic cholecystectomy will be diveided into 2 groups A \& B . Group A will receive local anesthetic wound infiltration and group B will receive Transversus abdominal plane block as a post operative analgesia. the time for request of first rescue analgesia between the 2 groups will be compared
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Aug 2024
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 11, 2025
CompletedFirst Submitted
Initial submission to the registry
January 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 31, 2025
CompletedJanuary 31, 2025
January 1, 2025
5 months
January 22, 2025
January 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
first rescue analgesia
time of requirement of first rescue analgesia will be compared between group a and group b
from enrollment to 24 hours post operation
Study Arms (2)
Group A: local anesthetic infiltration at port sites
ACTIVE COMPARATORGroup A patient's will receive local anesthetic wound infiltration at port sites with inj Bupivacaine (Bupivacaine Hydrochloride) 0.5%
Group B : TAP block
ACTIVE COMPARATORGroup b will receive Transversus Abdominal Plane (TAP) block at both sides using inj bupivacaine (Bupivacaine Hydrochloride) 0.25%
Interventions
Group A will receive local wound infiltration at port sites with inj bupivacaine (bupivacaine Hydrochloride) 0.5 % Group B will receive Transversus Abdominal Plane Block on both sides by inj bupivacaine (bupivacaine Hydrochloride) 0.25%
Eligibility Criteria
You may qualify if:
- both gender patients undergoing elective laparoscopic cholecystectomy ASA physical status classification 1 \& 2
You may not qualify if:
- patients with chronic pain patients unable to understand NRS pain scale conversion of laparoscopic to open cholecystectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PAF hospital Faisal base
Karachi, Sindh, 20006, Pakistan
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 22, 2025
First Posted
January 31, 2025
Study Start
August 5, 2024
Primary Completion
January 11, 2025
Study Completion
January 11, 2025
Last Updated
January 31, 2025
Record last verified: 2025-01